Haplotype analysis in prenatal diagnosis and carrier identification of Salla disease.

Por Schleutker, J, Sistonen, P, Aula, P
Publicado em 1996

C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk

Por Eklund, C M, Tammela, T L J, Schleutker, J, Hurme, M
Publicado em 2009

Linkage of a new mutation in the proteolipid protein (PLP) gene to Pelizaeus-Merzbacher disease (PMD) in a large Finnish kindred.

Por Pratt, V M, Kiefer, J R, Lähdetie, J, Schleutker, J, Hodes, M E, Dlouhy, S R
Publicado em 1993

Lysosomal free sialic acid storage disorders with different phenotypic presentations--infantile-form sialic acid storage disease and Salla disease--represent allelic disorders on 6...

Por Schleutker, J, Leppänen, P, Månsson, J E, Erikson, A, Weissenbach, J, Peltonen, L, Aula, P
Publicado em 1995

BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland

Por Ikonen, T, Matikainen, M, Syrjakoski, K, Mononen, N, Koivisto, P, Rokman, A, Seppala, E, Kallioniemi, O, Tammela, T, Schleutker, J
Publicado em 2003

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

Por Mononen, N, Ikonen, T, Syrjäkoski, K, Matikainen, M, Schleutker, J, Tammela, T L J, Koivisto, P A, Kallioniemi, O P
Publicado em 2001

CHEK2 variants associate with hereditary prostate cancer

Por Seppälä, E H, Ikonen, T, Mononen, N, Autio, V, Rökman, A, Matikainen, M P, Tammela, T L J, Schleutker, J
Publicado em 2003

The genetic locus for free sialic acid storage disease maps to the long arm of chromosome 6.

Por Haataja, L., Schleutker, J., Laine, A. P., Renlund, M., Savontaus, M. L., Dib, C., Weissenbach, J., Peltonen, L., Aula, P.
Publicado em 1994

No fumarate hydratase (FH) mutations in hereditary prostate cancer

Por Lehtonen, R, Kiuru, M, Rokman, A, Ikonen, T, Cunningham, J, Schaid, D, Matikainen, M, Nupponen, N, Karhu, A, Kallioniemi, O, Thibodeau, S, Schleutker, J, Aaltonen, L
Publicado em 2003

Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation‐negative breast cancer but not in other malignanc...

Por Karppinen, S‐M, Barkardottir, R B, Backenhorn, K, Sydenham, T, Syrjäkoski, K, Schleutker, J, Ikonen, T, Pylkäs, K, Rapakko, K, Erkko, H, Johannesdottir, G, Gerdes, A‐M, Thomassen, M, Agnarsson, B A, Grip, M, Kallioniemi, A, Kere, J, Aaltonen, L A, Arason, A, Møller, P, Kruse, T A, Borg, Å, Winqvist, R
Publicado em 2006

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

Por FitzGerald, L. M., Zhao, S., Leonardson, A., Geybels, M. S., Kolb, S., Lin, D. W., Wright, J. L., Eeles, R., Kote-Jarai, Z., Govindasami, K., Giles, G. G., Southey, M. C., Schleutker, J., Tammela, T. L., Sipeky, C., Penney, K. L., Stampfer, M. J., Gronberg, H., Wiklund, F., Stattin, P., Hugosson, J., Karyadi, D. M., Ostrander, E. A., Feng, Z., Stanford, J. L.
Publicado no Prostate Cancer Prostatic Dis (2018)